A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
| Autor: | Alan H. Lazarus, John Freedman, Andrew R. Crow, John W. Semple, Seng Song |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Recombinant Fusion Proteins Immunology CD11c Pharmacology Nitric Oxide Biochemistry Mice Immune system hemic and lymphatic diseases Internal medicine medicine Animals Macrophage Chemokine CCL4 Receptor Chemokine CCL3 Mice Knockout Purpura Thrombocytopenic Idiopathic Hematology biology Interleukin-12 Subunit p40 Platelet Count Tumor Necrosis Factor-alpha business.industry Macrophages Receptors IgG Immunoglobulins Intravenous Receptors Interleukin-1 Dendritic Cells Cell Biology Macrophage Inflammatory Proteins Receptor antagonist Interleukin-10 Mice Inbred C57BL Interleukin 1 Receptor Antagonist Protein Mechanism of action biology.protein Cytokines Interleukin-4 medicine.symptom Antibody business Interleukin Receptor Common gamma Subunit |
| Zdroj: | Blood. 109:155-158 |
| ISSN: | 1528-0020 0006-4971 |
| Popis: | The exact mechanism of action of IVIg in the amelioration of immune thrombocytopenic purpura (ITP) is still unclear. Studies have suggested that IVIg may function through the regulation of cytokines, including interleukin-1 receptor antagonist (IL-1Ra), an inhibitor of phagocytosis. Using a mouse model relevant to ITP, we confirm an increase in mouse serum levels of IL-1Ra after exposure to IVIg, yet a recombinant IL-1Ra did not ameliorate thrombocytopenia. IVIg has also been shown to affect the expression of other regulatory cytokines. We have also recently established that IVIg specifically targets activating FcγRs on CD11c+ dendritic cells (DCs) as its primary mechanism of action in the amelioration of murine ITP. Herein, we show that IVIg functions therapeutically in mice lacking specific cytokines or their receptors that can potentially affect DC/macrophage function (IL-1 receptor, IL-4, IL-10, IL-12β, TNF-α, IFN-γ receptor, MIP-1α). This suggests that while IVIg may mediate the release of a variety of cytokines, the cytokines tested do not directly participate in the mechanism of IVIg action. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|